Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 104
CASE REPORT
Year : 2016  |  Volume : 8  |  Issue : 4  |  Page : 194-196

Tocilizumab efficacy in a patient with positive anti-CCP chronic Lyme arthritis


1 Department of Medicine, Technion Institute of Technology, Bnai Zion Medical Center, Haifa, Israel
2 Department of Medicine, Technion Institute of Technology; Department of Rheumatology, Bnai Zion Medical Center, Haifa, Israel
3 Department of Medicine, Technion Institute of Technology; Department of Internal Medicine A, Bnai Zion Medical Center, Haifa, Israel

Correspondence Address:
Julianna Hirsch
Faculty of Medicine, Technion Institute of Technology, Haifa, Israel. 32 Hasharon #5 Haifa
Israel
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1947-2714.179960

Rights and Permissions

Context: Lyme arthritis, a manifestation of tick-borne Lyme disease, can prove to be refractory to classic treatment. Case Report: We present a case of a 48-year-old male, diagnosed with chronic Lyme arthritis, refractory to recurrent and prolonged courses of doxycycline, ceftriaxone, as well as hydroxychloroquine and methotrexate. The patient responded partially to tumor necrosis factor (TNF)-alpha blockade by etanercept and, finally, entered long-term remission after his treatment was switched to tocilizumab. Conclusion: Off label treatment by biologic disease modifying antirheumatic drugs can be considered in selected patients with severe antibiotic-resistant Lyme arthritis.C.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1669    
    Printed40    
    Emailed0    
    PDF Downloaded283    
    Comments [Add]    

Recommend this journal